Literature DB >> 26687150

Initial Observations of the Effects of Calcium Chloride Infusions in Pediatric Patients with Low Cardiac Output.

Konstantin Averin1, Chet Villa2, Catherine D Krawczeski2,3, Jesse Pratt4, Eileen King4, John L Jefferies2, David P Nelson2, David S Cooper2, Thomas D Ryan2, Jaclyn Sawyer5, Jeffrey A Towbin2,6, Angela Lorts2.   

Abstract

Myocardial contractility and relaxation are highly dependent on calcium homeostasis. Immature myocardium, as in pediatric patients, is thought to be more dependent on extracellular calcium for optimal function. For this reason, intravenous calcium chloride infusions may improve myocardial function in the pediatric patient. The objectives of this study were to report the hemodynamic changes seen after administration of continuous calcium chloride to critically ill children. We retrospectively identified pediatric patients (newborn to 17 years old) with hemodynamic instability admitted to the cardiac ICU between May 2011 and May 2012 who received a continuous infusion of calcium chloride. The primary outcome was improvement in cardiac output, assessed by arterial-mixed venous oxygen saturation (A-V) difference. Sixty-eight patients, mean age 0.87 ± 2.67 years, received a total of 116 calcium infusions. Calcium chloride infusions resulted in significant improvements in primary and secondary measures of cardiac output at 2 and 6 h. Six hours after calcium initiation, A-V oxygen saturation difference decreased by 7.4 % (32.6 ± 2.1 to 25.2 ± 2.0 %, p < 0.001), rSO2 increased by 5.5 % (63.1 vs 68.6 %, p < 0.001), and serum lactate decreased by 0.9 mmol/l (3.3 vs 2.4 mmol/l, p < 0.001) with no change in HR (149.1 vs 145.6 bpm p = 0.07). Urine output increased 0.66 ml/kg/h in the 8-h period after calcium initiation when compared to pre-initiation (p = 0.003). Neonates had the strongest evidence of effectiveness with other age groups trending toward significance. Calcium chloride infusions improve markers of cardiac output in a heterogenous group of pediatric patients in a cardiac ICU. Neonates appear to derive the most benefit from utilization of these infusions.

Entities:  

Keywords:  Cardiogenic shock; Congenital heart disease; Heart failure; Intensive care; Neonates; Vasoactive

Mesh:

Substances:

Year:  2015        PMID: 26687150     DOI: 10.1007/s00246-015-1322-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  32 in total

1.  Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.

Authors:  M S Nieminen; J Akkila; G Hasenfuss; F X Kleber; L A Lehtonen; V Mitrovic; O Nyquist; W J Remme
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

2.  Initial single-center experience with levosimendan infusion for perioperative management of univentricular heart with ductal-dependent systemic circulation.

Authors:  Cristiana Garisto; Isabella Favia; Zaccaria Ricci; Luca Di Chiara; Stefano Morelli; Chiara Giorni; Vincenzo Vitale; Sergio Picardo; Roberto M Di Donato
Journal:  World J Pediatr Congenit Heart Surg       Date:  2010-10

3.  Developmental changes in the ultrastructure and sarcomere shortening of the isolated rabbit ventricular myocyte.

Authors:  R Nassar; M C Reedy; P A Anderson
Journal:  Circ Res       Date:  1987-09       Impact factor: 17.367

4.  Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Authors:  M T Slawsky; W S Colucci; S S Gottlieb; B H Greenberg; E Haeusslein; J Hare; S Hutchins; C V Leier; T H LeJemtel; E Loh; J Nicklas; D Ogilby; B N Singh; W Smith
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

Review 5.  Newer inotropes in pediatric heart failure.

Authors:  Timothy M Hoffman
Journal:  J Cardiovasc Pharmacol       Date:  2011-08       Impact factor: 3.105

6.  Levosimendan for low cardiac output: a pediatric experience.

Authors:  Jonathan R Egan; Andrew J B Clarke; Stephen Williams; Andrew D Cole; Julian Ayer; Stephen Jacobe; Richard B Chard; David S Winlaw
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

7.  Adverse effects of dopamine on systemic hemodynamic status and oxygen transport in neonates after the Norwood procedure.

Authors:  Jia Li; Gencheng Zhang; Helen Holtby; Tilman Humpl; Christopher A Caldarone; Glen S Van Arsdell; Andrew N Redington
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

8.  A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia.

Authors:  K J Barrington; N N Finer; W K Chan
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

9.  Intermittent levosimendan treatment in patients with severe congestive heart failure.

Authors:  Petri O Tuomainen; Jarkko Magga; Pekka Timonen; Kati Miettinen; Minna Kurttila; Esko Vanninen; Tomi Laitinen; Kirsi Timonen; Kari Punnonen; Ilkka Parviainen; Ari Uusaro; Olli Vuolteenaho; Matti Kivikko; Keijo Peuhkurinen
Journal:  Clin Res Cardiol       Date:  2013-03-17       Impact factor: 5.460

10.  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.

Authors:  Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

View more
  4 in total

1.  Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.

Authors:  Karan B Karki; Jeffrey A Towbin; Camden Harrell; James Tansey; Joseph Krebs; William Bigelow; Arun Saini; Sachin D Tadphale
Journal:  Pediatr Cardiol       Date:  2019-05-07       Impact factor: 1.655

Review 2.  Impact of Medical Interventions and Comorbidities on Norwood Admission for Patients with Hypoplastic Left Heart Syndrome.

Authors:  Rohit S Loomba; Jacqueline Rausa; Juan S Farias; Enrique G Villarreal; Sebastian Acosta; Fabio Savorgnan; Saul Flores
Journal:  Pediatr Cardiol       Date:  2022-01-15       Impact factor: 1.655

3.  A retrospective analysis of calcium levels in pediatric trauma patients.

Authors:  Brian G Cornelius; Daniel Clark; Ben Williams; Anna Rogers; Andreea Popa; Phillip Kilgore; Urska Cvek; Marjan Trutschl; Kevin Boykin; Angela Cornelius
Journal:  Int J Burns Trauma       Date:  2021-06-15

4.  Calcium Chloride Infusions are Not Associated with Improved Outcomes in Neonates Undergoing Cardiac Operations.

Authors:  Laura E Murray; Holly Burchett; Shahryar M Chowdhury; A Lauren Haney; Marc Hassid; Jacob R Strelow; Eric M Graham; Minoo N Kavarana; Jason R Buckley
Journal:  Pediatr Cardiol       Date:  2021-09-14       Impact factor: 1.838

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.